Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 205 to 214 of 214 entries
Sorted by: Best Match Show Resources per page
Methodology to Determine Cause of Death for Stillbirths and Neonatal Deaths Using Automated Case Reports and a Cause-of-Death Panel.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Hwang KS, Parlberg L, Aceituno A, Moore JL, Goudar SS, Sunder Tikmani S, Saleem S, Guruprasad G, Revankar A, Habib Z, Dhaded SM, Yogesh Kumar S, Raghoji C, Kusugur V, Pujar S, Roujani S, McClure EM, Goldenberg RL.
PMID: 34910185
Clin Infect Dis. 2021 Dec 15;73:S368-S373. doi: 10.1093/cid/ciab811.

BACKGROUND: Review of data from multiple sources is often necessary to determine cause of death for stillbirths and neonatal deaths, especially in low- to middle-income countries (LMICs) where available data may vary. The minimally invasive tissue sampling (MITS) procedure...

Cite
Hwang KS, Parlberg L, Aceituno A, et al. Methodology to Determine Cause of Death for Stillbirths and Neonatal Deaths Using Automated Case Reports and a Cause-of-Death Panel. Clin Infect Dis. 2021;73:S368-S373doi: 10.1093/cid/ciab811.
Hwang, K. S., Parlberg, L., Aceituno, A., Moore, J. L., Goudar, S. S., Sunder Tikmani, S., Saleem, S., Guruprasad, G., Revankar, A., Habib, Z., Dhaded, S. M., Yogesh Kumar, S., Raghoji, C., Kusugur, V., Pujar, S., Roujani, S., McClure, E. M., & Goldenberg, R. L. (2021). Methodology to Determine Cause of Death for Stillbirths and Neonatal Deaths Using Automated Case Reports and a Cause-of-Death Panel. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73S368-S373. https://doi.org/10.1093/cid/ciab811
Hwang, Kay S, et al. "Methodology to Determine Cause of Death for Stillbirths and Neonatal Deaths Using Automated Case Reports and a Cause-of-Death Panel." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73 (2021): S368-S373. doi: https://doi.org/10.1093/cid/ciab811
Hwang KS, Parlberg L, Aceituno A, Moore JL, Goudar SS, Sunder Tikmani S, Saleem S, Guruprasad G, Revankar A, Habib Z, Dhaded SM, Yogesh Kumar S, Raghoji C, Kusugur V, Pujar S, Roujani S, McClure EM, Goldenberg RL. Methodology to Determine Cause of Death for Stillbirths and Neonatal Deaths Using Automated Case Reports and a Cause-of-Death Panel. Clin Infect Dis. 2021 Dec 15;73:S368-S373. doi: 10.1093/cid/ciab811. PMID: 34910185.
Copy Download .nbib Format: NLM
Post-mastectomy and post-breast conservation surgery pain syndrome: a review of etiologies, risk prediction, and trends in management.

Translational cancer research

Chen VE, Greenberger BA, Shi Z, Gajjar S, Shi W, Mourad WF, Yan W.
PMID: 33828953
Transl Cancer Res. 2020 Jan;9:S77-S85. doi: 10.21037/tcr.2019.06.46.

Postmastectomy pain syndrome (PMPS) or breast conservation surgery (BCS) pain syndrome could be long-term and lead to disability and impairment on body and social function. The pain syndromes are not uncommon in breast cancer patients. It can affect social,...

Cite
Chen VE, Greenberger BA, Shi Z, et al. Post-mastectomy and post-breast conservation surgery pain syndrome: a review of etiologies, risk prediction, and trends in management. Transl Cancer Res. 2020;9:S77-S85doi: 10.21037/tcr.2019.06.46.
Chen, V. E., Greenberger, B. A., Shi, Z., Gajjar, S., Shi, W., Mourad, W. F., & Yan, W. (2020). Post-mastectomy and post-breast conservation surgery pain syndrome: a review of etiologies, risk prediction, and trends in management. Translational cancer research, 9S77-S85. https://doi.org/10.21037/tcr.2019.06.46
Chen, Victor E, et al. "Post-mastectomy and post-breast conservation surgery pain syndrome: a review of etiologies, risk prediction, and trends in management." Translational cancer research vol. 9 (2020): S77-S85. doi: https://doi.org/10.21037/tcr.2019.06.46
Chen VE, Greenberger BA, Shi Z, Gajjar S, Shi W, Mourad WF, Yan W. Post-mastectomy and post-breast conservation surgery pain syndrome: a review of etiologies, risk prediction, and trends in management. Transl Cancer Res. 2020 Jan;9:S77-S85. doi: 10.21037/tcr.2019.06.46. PMID: 33828953; PMCID: PMC8022993.
Copy Download .nbib Format: NLM
Defining Right Ventricular Dysfunction in Acute Respiratory Distress Syndrome.

Journal of cardiothoracic and vascular anesthesia

Dugar S, Sato R, Zochios V, Duggal A, Vallabhajosyula S.
PMID: 34583852
J Cardiothorac Vasc Anesth. 2021 Sep 16; doi: 10.1053/j.jvca.2021.09.001. Epub 2021 Sep 16.

No abstract available.

Cite
Dugar S, Sato R, Zochios V, et al. Defining Right Ventricular Dysfunction in Acute Respiratory Distress Syndrome. J Cardiothorac Vasc Anesth. 2021;doi: 10.1053/j.jvca.2021.09.001.
Dugar, S., Sato, R., Zochios, V., Duggal, A., Vallabhajosyula, S. (2021). Defining Right Ventricular Dysfunction in Acute Respiratory Distress Syndrome. Journal of cardiothoracic and vascular anesthesia, . https://doi.org/10.1053/j.jvca.2021.09.001
Dugar, Siddharth, et al. "Defining Right Ventricular Dysfunction in Acute Respiratory Distress Syndrome." Journal of cardiothoracic and vascular anesthesia vol. (2021). doi: https://doi.org/10.1053/j.jvca.2021.09.001
Dugar S, Sato R, Zochios V, Duggal A, Vallabhajosyula S. Defining Right Ventricular Dysfunction in Acute Respiratory Distress Syndrome. J Cardiothorac Vasc Anesth. 2021 Sep 16; doi: 10.1053/j.jvca.2021.09.001. Epub 2021 Sep 16. PMID: 34583852.
Copy Download .nbib Format: NLM
A novel radiographic marker of sarcopenia with prognostic value in glioblastoma.

Clinical neurology and neurosurgery

Huq S, Khalafallah AM, Ruiz-Cardozo MA, Botros D, Oliveira LAP, Dux H, White T, Jimenez AE, Gujar SK, Sair HI, Pillai JJ, Mukherjee D.
PMID: 34186275
Clin Neurol Neurosurg. 2021 Aug;207:106782. doi: 10.1016/j.clineuro.2021.106782. Epub 2021 Jun 24.

OBJECTIVE: Sarcopenia is an important prognostic consideration in surgical oncology that has received relatively little attention in brain tumor patients. Temporal muscle thickness (TMT) has recently been proposed as a novel radiographic marker of sarcopenia that can be efficiently...

Cite
Huq S, Khalafallah AM, Ruiz-Cardozo MA, et al. A novel radiographic marker of sarcopenia with prognostic value in glioblastoma. Clin Neurol Neurosurg. 2021;207:106782doi: 10.1016/j.clineuro.2021.106782.
Huq, S., Khalafallah, A. M., Ruiz-Cardozo, M. A., Botros, D., Oliveira, L. A. P., Dux, H., White, T., Jimenez, A. E., Gujar, S. K., Sair, H. I., Pillai, J. J., & Mukherjee, D. (2021). A novel radiographic marker of sarcopenia with prognostic value in glioblastoma. Clinical neurology and neurosurgery, 207106782. https://doi.org/10.1016/j.clineuro.2021.106782
Huq, Sakibul, et al. "A novel radiographic marker of sarcopenia with prognostic value in glioblastoma." Clinical neurology and neurosurgery vol. 207 (2021): 106782. doi: https://doi.org/10.1016/j.clineuro.2021.106782
Huq S, Khalafallah AM, Ruiz-Cardozo MA, Botros D, Oliveira LAP, Dux H, White T, Jimenez AE, Gujar SK, Sair HI, Pillai JJ, Mukherjee D. A novel radiographic marker of sarcopenia with prognostic value in glioblastoma. Clin Neurol Neurosurg. 2021 Aug;207:106782. doi: 10.1016/j.clineuro.2021.106782. Epub 2021 Jun 24. PMID: 34186275.
Copy Download .nbib Format: NLM
COVID-19 in Bangladesh: A Deeper Outlook into The Forecast with Prediction of Upcoming Per Day Cases Using Time Series.

Procedia computer science

Mohammad Masum AK, Khushbu SA, Keya M, Abujar S, Hossain SA.
PMID: 33520018
Procedia Comput Sci. 2020;178:291-300. doi: 10.1016/j.procs.2020.11.031. Epub 2020 Dec 07.

A global pandemic on March 11th of 2020, which was initially renowned by the World Health Organization (WHO) revealed the coronavirus (the COVID-19 epidemic). Coronavirus was flown in -December 2019 in Wuhan, Hubei region in China. Currently, the situation...

Cite
Mohammad Masum AK, Khushbu SA, Keya M, et al. COVID-19 in Bangladesh: A Deeper Outlook into The Forecast with Prediction of Upcoming Per Day Cases Using Time Series. Procedia Comput Sci. 2020;178:291-300doi: 10.1016/j.procs.2020.11.031.
Mohammad Masum, A. K., Khushbu, S. A., Keya, M., Abujar, S., & Hossain, S. A. (2020). COVID-19 in Bangladesh: A Deeper Outlook into The Forecast with Prediction of Upcoming Per Day Cases Using Time Series. Procedia computer science, 178291-300. https://doi.org/10.1016/j.procs.2020.11.031
Mohammad Masum, Abu Kaisar, et al. "COVID-19 in Bangladesh: A Deeper Outlook into The Forecast with Prediction of Upcoming Per Day Cases Using Time Series." Procedia computer science vol. 178 (2020): 291-300. doi: https://doi.org/10.1016/j.procs.2020.11.031
Mohammad Masum AK, Khushbu SA, Keya M, Abujar S, Hossain SA. COVID-19 in Bangladesh: A Deeper Outlook into The Forecast with Prediction of Upcoming Per Day Cases Using Time Series. Procedia Comput Sci. 2020;178:291-300. doi: 10.1016/j.procs.2020.11.031. Epub 2020 Dec 07. PMID: 33520018; PMCID: PMC7837051.
Copy Download .nbib Format: NLM
A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer.

Frontiers in oncology

Xu Z, Gujar H, Fu G, Ahmadi H, Bhanvadia S, Weisenberger DJ, Jin B, Gill PS, Gill I, Daneshmand S, Siegmund KD, Liang G.
PMID: 33659216
Front Oncol. 2021 Feb 15;11:614927. doi: 10.3389/fonc.2021.614927. eCollection 2021.

BACKGROUND: Muscle-invasive bladder cancer (MIBC) accounts for approximately 20% of all urothelial bladder carcinomas (UBC) at time of diagnosis, and up to 30% of patients with non-muscle invasive UBC will progress to MIBC over time. An increasing body of...

Cite
Xu Z, Gujar H, Fu G, et al. A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer. Front Oncol. 2021;11:614927doi: 10.3389/fonc.2021.614927.
Xu, Z., Gujar, H., Fu, G., Ahmadi, H., Bhanvadia, S., Weisenberger, D. J., Jin, B., Gill, P. S., Gill, I., Daneshmand, S., Siegmund, K. D., & Liang, G. (2021). A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer. Frontiers in oncology, 11614927. https://doi.org/10.3389/fonc.2021.614927
Xu, Zhijie, et al. "A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer." Frontiers in oncology vol. 11 (2021): 614927. doi: https://doi.org/10.3389/fonc.2021.614927
Xu Z, Gujar H, Fu G, Ahmadi H, Bhanvadia S, Weisenberger DJ, Jin B, Gill PS, Gill I, Daneshmand S, Siegmund KD, Liang G. A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer. Front Oncol. 2021 Feb 15;11:614927. doi: 10.3389/fonc.2021.614927. eCollection 2021. PMID: 33659216; PMCID: PMC7917237.
Copy Download .nbib Format: NLM
Use of person-centred language among scientific research focused on childhood obesity.

Pediatric obesity

Fisch C, Whelan J, Evans S, Whitaker LA, Gajjar S, Ali L, Fugate C, Puhl R, Hartwell M.
PMID: 34928545
Pediatr Obes. 2021 Dec 20;e12879. doi: 10.1111/ijpo.12879. Epub 2021 Dec 20.

BACKGROUND: Stigma towards children with obesity can begin as early as 3 years old, leading to increased risk for poorer mental health outcomes and lower quality of life. This includes discriminatory language used by peers and adults, which may...

Cite
Fisch C, Whelan J, Evans S, et al. Use of person-centred language among scientific research focused on childhood obesity. Pediatr Obes. 2021;e12879doi: 10.1111/ijpo.12879.
Fisch, C., Whelan, J., Evans, S., Whitaker, L. A., Gajjar, S., Ali, L., Fugate, C., Puhl, R., & Hartwell, M. (2021). Use of person-centred language among scientific research focused on childhood obesity. Pediatric obesity, e12879. https://doi.org/10.1111/ijpo.12879
Fisch, Claudia, et al. "Use of person-centred language among scientific research focused on childhood obesity." Pediatric obesity vol. (2021): e12879. doi: https://doi.org/10.1111/ijpo.12879
Fisch C, Whelan J, Evans S, Whitaker LA, Gajjar S, Ali L, Fugate C, Puhl R, Hartwell M. Use of person-centred language among scientific research focused on childhood obesity. Pediatr Obes. 2021 Dec 20;e12879. doi: 10.1111/ijpo.12879. Epub 2021 Dec 20. PMID: 34928545.
Copy Download .nbib Format: NLM
Central serous chorioretinopathy imaging biomarkers.

The British journal of ophthalmology

Singh SR, Iovino C, Zur D, Masarwa D, Iglicki M, Gujar R, Lupidi M, Maltsev DS, Bousquet E, Bencheqroun M, Amoroso F, Lima LH, Padhy SK, Govindahari V, Chandra K, Souied EH, Rodriguez FJ, Daza LA, Rios HA, Cagini C, Peiretti E, Behar-Cohen F, Chhablani J.
PMID: 33288526
Br J Ophthalmol. 2020 Dec 07; doi: 10.1136/bjophthalmol-2020-317422. Epub 2020 Dec 07.

PURPOSE: To identify the factors predicting the visual and anatomical outcomes in eyes with central serous chorioretinopathy (CSCR) through 12 months.METHODS: Patients with diagnosis of CSCR, either acute or chronic, were included in this multicentric, retrospective study. Demographic factors;...

Cite
Singh SR, Iovino C, Zur D, et al. Central serous chorioretinopathy imaging biomarkers. Br J Ophthalmol. 2020;doi: 10.1136/bjophthalmol-2020-317422.
Singh, S. R., Iovino, C., Zur, D., Masarwa, D., Iglicki, M., Gujar, R., Lupidi, M., Maltsev, D. S., Bousquet, E., Bencheqroun, M., Amoroso, F., Lima, L. H., Padhy, S. K., Govindahari, V., Chandra, K., Souied, E. H., Rodriguez, F. J., Daza, L. A., Rios, H. A., Cagini, C., Peiretti, E., Behar-Cohen, F., & Chhablani, J. (2020). Central serous chorioretinopathy imaging biomarkers. The British journal of ophthalmology, . https://doi.org/10.1136/bjophthalmol-2020-317422
Singh, Sumit Randhir, et al. "Central serous chorioretinopathy imaging biomarkers." The British journal of ophthalmology vol. (2020). doi: https://doi.org/10.1136/bjophthalmol-2020-317422
Singh SR, Iovino C, Zur D, Masarwa D, Iglicki M, Gujar R, Lupidi M, Maltsev DS, Bousquet E, Bencheqroun M, Amoroso F, Lima LH, Padhy SK, Govindahari V, Chandra K, Souied EH, Rodriguez FJ, Daza LA, Rios HA, Cagini C, Peiretti E, Behar-Cohen F, Chhablani J. Central serous chorioretinopathy imaging biomarkers. Br J Ophthalmol. 2020 Dec 07; doi: 10.1136/bjophthalmol-2020-317422. Epub 2020 Dec 07. PMID: 33288526.
Copy Download .nbib Format: NLM
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial.

Medical oncology (Northwood, London, England)

Ghonaim E, El-Haggar S, Gohar S.
PMID: 34357466
Med Oncol. 2021 Aug 06;38(9):108. doi: 10.1007/s12032-021-01558-y.

Cisplatin is used to treat solid malignancies including head and neck cancer. However, nephrotoxicity limits its use. In this study, we looked for a possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity. We used novel biomarkers for early detection...

Cite
Ghonaim E, El-Haggar S, Gohar S. Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial. Med Oncol. 2021;38(9):108doi: 10.1007/s12032-021-01558-y.
Ghonaim, E., El-Haggar, S., & Gohar, S. (2021). Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial. Medical oncology (Northwood, London, England), 38(9), 108. https://doi.org/10.1007/s12032-021-01558-y
Ghonaim, Eman, et al. "Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial." Medical oncology (Northwood, London, England) vol. 38,9 (2021): 108. doi: https://doi.org/10.1007/s12032-021-01558-y
Ghonaim E, El-Haggar S, Gohar S. Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial. Med Oncol. 2021 Aug 06;38(9):108. doi: 10.1007/s12032-021-01558-y. PMID: 34357466.
Copy Download .nbib Format: NLM
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR.
PMID: 34971849
J Clin Virol. 2022 Jan;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21.

Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized....

Cite
Anantharaj A, Gujjar S, Verma N, et al. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2021;146:105060doi: 10.1016/j.jcv.2021.105060.
Anantharaj, A., Gujjar, S., Verma, N., Khan, N. A., Shaman, H., Sharanabasava, P., Das, A., Pandey, R., Pandey, A. K., & Medigeshi, G. R. (2022). Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105060. https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj, Anbalagan, et al. "Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2022): 105060. doi: https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2022 Jan;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21. PMID: 34971849; PMCID: PMC8687718.
Copy Download .nbib Format: NLM
Showing 205 to 214 of 214 entries